ArticleBritish journal of cancer2004

The efficacy of Herceptin therapies is influenced by the expression of other erbB receptors, their ligands and the activation of downstream signalling proteins.

B L Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.